Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the page template or CMS; no study content or user-facing information appears to have changed.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor metadata update to the page rather than a substantive change to the study details.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page's revision stamp was updated from v3.6.2 to v3.6.3, signaling a minor update to the Study Details page without altering its content or conclusions.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page footer shows a new revision tag, v3.6.2, and the previous revision tag, v3.6.0, was removed. This reflects a small platform update with no changes to the study details or user-facing content.SummaryDifference0.1%

- Check77 days agoChange DetectedNew help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note stating no longer looking for participants, plus a revision tag showing v3.6.0. The text label for a section was changed from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check84 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a page version update. The change does not alter trial details, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.